SCOTTSDALE, Ariz., May 31, 2012 /PRNewswire/ -- Kowa Pharmaceuticals America, Inc. and Eli Lilly and Company (NYSE:LLY) today announced results of the PREVAIL U.S.

Levels of non-high-density lipoprotein cholesterol (non-HDL-C) among statin-treated patients appears to be associated with the risk of developing a major cardiovascular event, such as a heart attack or stroke, as are levels of low-density lipoprotein cholesterol (LDL-C) and apolipoprotein B.

ANY LAB TEST NOW®’s Advanced Heart Health Screening Tests Can Detect What the Standard, Run of the Mill Lipid Test Cannot Alpharetta,

Coronary patients with low levels of an immune system antibody called anti-PC, which neutralizes parts of the 'bad' cholesterol, run a greater risk of suffering complications following an acute cardiac episode and thus of premature death.

CARLSBAD, Calif., Dec. 15, 2011 /PRNewswire/ -- Isis Pharmaceuticals, Inc.